Clinical Research Trials that are currently enrolling:

A Phase 2, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Multi-center study to evaluate the Efficacy and Safety of Once-daily Administration of a Phosphodiesterase 5 Inhibitor in Adults with Type 2 Diabetes and Overt Nephropathy.

A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Clinical Activity and Pharmacokinetics of Bosutinib versus Placebo in Subjects with Autosomal Dominant Polycystic Kidney Disease.

A Phase 2b, Prospective, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate Efficacy and Safety of Atrasentan, including Thoracic Bioimpedance, in Type 2 Diabetic Subjects with Nephropathy.

A Phase 2, Randomized, Open-Label, Dose Titration, Efficacy and Safety Study of FG-4592 in Non-Dialysis Chronic Kidney Disease Patients with Anemia.

 If you would like further information regarding Clinical Research Trials, please contact Marcee Bonner at (225) 757-7118 or via email at mbonner@renalassociates.com

 Additional Clinical Research Websites:

http://www.clinicaltrials.gov

http://www.pkdcure.org

_{Back to top}